Healthcare Equipment and Supplies
Company Overview of LumiGene Technologies Incorporated
LumiGene Technologies Incorporated, a molecular diagnostics company, develops and commercializes point-of-care products to diagnose and treat infectious diseases. The company provides POSiChek Diagnostic System, a nucleic acid DNA/RNA testing system that automates the process of preparing and amplifying nucleic acid in order to detect disease causing pathogens. It serves healthcare customers, such as hospitals, walk-in clinics, physician offices, and nursing homes; and veterinary, food safety testing, agricultural, environmental monitoring, and biothreat monitoring markets. The company was founded in 2002 and is based in Mississauga, Canada.
2320 Tedlo Street
Mississauga, ON L5A 4A2
Founded in 2002
Key Executives for LumiGene Technologies Incorporated
Similar Private Companies By Industry
|A.R. Medicom, Inc.||Americas|
|ABK Biomedical Inc.||Americas|
|Adjuvant Therapeutics Inc.||Americas|
|Advanced Bioelectric Corp.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact LumiGene Technologies Incorporated, please visit www.lumigene.ca. Company data is provided by Capital IQ. Please use this form to report any data issues.